window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : August 14, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Pharmaceutical Partnerships

  • Digital & Data,Pharmaceuticals and therapeutics,Therapeutic Areas

    Tris Pharma partners with Calm Health and ADHD Central to support patients

    Tris Pharma has announced partnerships with Calm Health and ADHD [...]

    August 14, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Remepy raises $36M to advance Parkinson’s drug into Phase 3

    Remepy has raised $36M in a Series A financing round [...]

    August 14, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Adneuris licenses cebranopadol to Maruishi in $35M Japan and South Korea deal

    Adneuris Therapeutics has granted Maruishi Pharmaceutical exclusive rights to develop [...]

    August 7, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Regeneron enters radiopharmaceuticals through multi-programme collaboration with Telix in oncology expansion

    Regeneron Pharmaceuticals has entered the radiopharmaceuticals field through a multi-programme [...]

    May 5, 2026
  • Drug Delivery & Formulation,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Nanexa and Moderna sign licence and option agreement for Pharmashell drug delivery development

    Nanexa has entered into a licence and option agreement with [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    Chinese machinery deal accelerates Pakistan’s drug production

    A partnership between Chinese pharmaceutical machinery supplier Xin Weisheng and [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    BridgeBio sees strong launch for ATTR-CM drug Attruby and accelerates rare disease pipeline

    BridgeBio Pharma reported $36.7 million in US net revenue for [...]

    May 5, 2026
  • Biotech & Pharma Business

    Telix partners with Cardinal Health for Gozellix commercial distribution in the US

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Vaderis raises $152M and starts Phase 3 trial of engasertib in HHT
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • AC Immune gets FDA Fast Track for Parkinson’s immunotherapy ACI-7104
    Categories: Central Nervous System, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Bios Life launches with $25M funding and Tempus cancer AI partnership
    Categories: Biotech & Pharma Business, Digital & Data, Genomics and sequencing, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top